Queuine ameliorates impaired mitochondrial function caused by mt-tRNA


Journal

Journal of translational medicine
ISSN: 1479-5876
Titre abrégé: J Transl Med
Pays: England
ID NLM: 101190741

Informations de publication

Date de publication:
22 Aug 2024
Historique:
received: 09 06 2024
accepted: 04 08 2024
medline: 23 8 2024
pubmed: 23 8 2024
entrez: 22 8 2024
Statut: epublish

Résumé

Mitochondrial tRNA (mt-tRNA) variants have been found to cause disease. Post-transcriptional queuosine (Q) modifications of mt-tRNA can promote efficient mitochondrial mRNA translation. Q modifications of mt-tRNA Six patients (from four families) carrying mt-tRNA The variants included the m.5701 delA, m.5708 C > T, m.5709 C > T, and m.5698 G > A variants in mt-tRNA The study not only confirmed the pathogenicity of the m.5708 C > T variant but also explored the therapeutic potential of queuine in individuals with mt-tRNA

Sections du résumé

BACKGROUND BACKGROUND
Mitochondrial tRNA (mt-tRNA) variants have been found to cause disease. Post-transcriptional queuosine (Q) modifications of mt-tRNA can promote efficient mitochondrial mRNA translation. Q modifications of mt-tRNA
METHODS METHODS
Six patients (from four families) carrying mt-tRNA
RESULTS RESULTS
The variants included the m.5701 delA, m.5708 C > T, m.5709 C > T, and m.5698 G > A variants in mt-tRNA
CONCLUSIONS CONCLUSIONS
The study not only confirmed the pathogenicity of the m.5708 C > T variant but also explored the therapeutic potential of queuine in individuals with mt-tRNA

Identifiants

pubmed: 39175050
doi: 10.1186/s12967-024-05574-0
pii: 10.1186/s12967-024-05574-0
doi:

Substances chimiques

DNA, Mitochondrial 0
Nucleoside Q 57072-36-3
RNA, Mitochondrial 0
RNA, Transfer, Ala 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

780

Subventions

Organisme : National Natural Science Foundation of China
ID : 82171394
Organisme : National Natural Science Foundation of China
ID : 82071412
Organisme : National Natural Science Foundation of China
ID : 82301590
Organisme : Grants from the National Key R&D Program of China
ID : 2021YFC2700904
Organisme : Natural Science Foundation of Shandong Province
ID : ZR2023QH106
Organisme : China Postdoctoral Science Foundation
ID : 2023M742116
Organisme : Shandong Provincial Postdoctoral Innovation Talent Support Program
ID : SDBX2022061
Organisme : Key R&D Program of Shandong Province
ID : 2022ZLGX03

Informations de copyright

© 2024. The Author(s).

Références

Ng Y, Bindoff L, Gorman G, et al. Mitochondrial disease in adults: recent advances and future promise. Lancet Neurol. 2021;20:573–84.
doi: 10.1016/S1474-4422(21)00098-3 pubmed: 34146515
Gorman GS, Schaefer AM, Ng Y, et al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol. 2015;77:753–9.
doi: 10.1002/ana.24362 pubmed: 25652200 pmcid: 4737121
Chen X, Ji Y, Liu R, et al. Mitochondrial dysfunction: roles in skeletal muscle atrophy. J Transl Med. 2023;21:503.
doi: 10.1186/s12967-023-04369-z pubmed: 37495991 pmcid: 10373380
Ribas de Pouplana L. The mitochondrial tRNA conundrum. Nat Rev Mol Cell Biol. 2020;21:361.
doi: 10.1038/s41580-020-0220-5 pubmed: 32001807
Bai R, Balog A, Kiesler P, Arjona D, Cui H. Comment on the criteria for interpretation of mitochondrial tRNA variants. Genet Med. 2020;22:1418–9.
doi: 10.1038/s41436-020-0804-7 pubmed: 32418987
He F, Ye L, Miao P, Zhou J, Ding Y, Wang S. Long-term ketogenic diet therapy improves mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS): a case report. CNS Neurosci Ther. 2023;29:2717–20.
doi: 10.1111/cns.14274 pubmed: 37208962 pmcid: 10401076
Gorman G, Chinnery P, DiMauro S, Hirano M, Koga Y, McFarland R, Suomalainen A, Thorburn D, Zeviani M, Turnbull D. Mitochondrial diseases. Nat Rev Dis Primers. 2016;2:16080.
doi: 10.1038/nrdp.2016.80 pubmed: 27775730
Chen C, Guan MX. Induced pluripotent stem cells: ex vivo models for human diseases due to mitochondrial DNA mutations. J Biomed Sci. 2023;30:82.
doi: 10.1186/s12929-023-00967-7 pubmed: 37737178 pmcid: 10515435
Tomoda E, Nagao A, Shirai Y, Asano K, Suzuki T, Battersby BJ, Suzuki T. Restoration of mitochondrial function through activation of hypomodified tRNAs with pathogenic mutations associated with mitochondrial diseases. Nucleic Acids Res. 2023;51:7563–79.
doi: 10.1093/nar/gkad139 pubmed: 36928678 pmcid: 10415153
Hansen SH, Andersen ML, Cornett C, Gradinaru R, Grunnet N. A role for taurine in mitochondrial function. J Biomed Sci. 2010;17(Suppl 1):S23.
doi: 10.1186/1423-0127-17-S1-S23 pubmed: 20804598 pmcid: 2994382
Qi Q, Liu X, Fu F, Shen W, Cui S, Yan S, Zhang Y, Du Y, Tian T, Zhou X. Utilizing epigenetic modification as a reactive handle to regulate RNA function and CRISPR-Based gene regulation. J Am Chem Soc. 2023;145:11678–89.
doi: 10.1021/jacs.3c01864 pubmed: 37191624
Lin H, Miyauchi K, Harada T, et al. CO(2)-sensitive tRNA modification associated with human mitochondrial disease. Nat Commun. 2018;9:1875.
doi: 10.1038/s41467-018-04250-4 pubmed: 29760464 pmcid: 5951830
Zhao X, Ma D, Ishiguro K et al. Glycosylated queuosines in tRNAs optimize translational rate and post-embryonic growth. Cell 2023.
Delaunay S, Pascual G, Feng B, et al. Mitochondrial RNA modifications shape metabolic plasticity in metastasis. Nature. 2022;607:593–603.
doi: 10.1038/s41586-022-04898-5 pubmed: 35768510 pmcid: 9300468
Ueda S, Yagi M, Tomoda E, et al. Mitochondrial haplotype mutation alleviates respiratory defect of MELAS by restoring taurine modification in tRNA with 3243A > G mutation. Nucleic Acids Res. 2023;51:7480–95.
doi: 10.1093/nar/gkad591 pubmed: 37439353 pmcid: 10415116
Ohsawa Y, Hagiwara H, Nishimatsu SI, et al. Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial. J Neurol Neurosurg Psychiatry. 2019;90:529–36.
doi: 10.1136/jnnp-2018-317964 pubmed: 29666206
Ji K, Lin Y, Xu X, Wang W, Wang D, Zhang C, Li W, Zhao Y, Yan C. MELAS-associated m.5541C > T mutation caused instability of mitochondrial tRNA(trp) and remarkable mitochondrial dysfunction. J Med Genet. 2022;59:79–87.
doi: 10.1136/jmedgenet-2020-107323 pubmed: 33208382
Yokoyama S, Miyazawa T, Iitaka Y, Yamaizumi Z, Kasai H, Nishimura S. Three-dimensional structure of hyper-modified nucleoside Q located in the wobbling position of tRNA. Nature. 1979;282:107–9.
doi: 10.1038/282107a0 pubmed: 388227
Kulkarni S, Rubio M, Hegedűsová E, Ross R, Limbach P, Alfonzo J, Paris Z. Preferential import of queuosine-modified tRNAs into Trypanosoma Brucei mitochondrion is critical for organellar protein synthesis. Nucleic Acids Res. 2021;49:8247–60.
doi: 10.1093/nar/gkab567 pubmed: 34244755 pmcid: 8373054
Tuorto F, Legrand C, Cirzi C, Federico G, Liebers R, Müller M, Ehrenhofer-Murray AE, Dittmar G, Gröne HJ, Lyko F. Queuosine-modified tRNAs confer nutritional control of protein translation. Embo j 2018, 37.
Suzuki T, Yashiro Y, Kikuchi I, et al. Complete chemical structures of human mitochondrial tRNAs. Nat Commun. 2020;11:4269.
doi: 10.1038/s41467-020-18068-6 pubmed: 32859890 pmcid: 7455718
Müller M, Legrand C, Tuorto F, Kelly V, Atlasi Y, Lyko F, Ehrenhofer-Murray A. Queuine links translational control in eukaryotes to a micronutrient from bacteria. Nucleic Acids Res. 2019;47:3711–27.
doi: 10.1093/nar/gkz063 pubmed: 30715423 pmcid: 6468285
Lin Y, Xu X, Wang W, Liu F, Zhao D, Li D, Ji K, Li W, Zhao Y, Yan C. A mitochondrial myopathy-associated tRNA(ser(UCN)) 7453G > A mutation alters tRNA metabolism and mitochondrial function. Mitochondrion. 2021;57:1–8.
doi: 10.1016/j.mito.2020.11.015 pubmed: 33279600
Old S, Johnson M. Methods of microphotometric assay of succinate dehydrogenase and cytochrome c oxidase activities for use on human skeletal muscle. Histochem J. 1989;21:545–55.
doi: 10.1007/BF01753355 pubmed: 2556354
Roos S, Lindgren U, Ehrstedt C, Moslemi AR, Oldfors A. Mitochondrial DNA depletion in single fibers in a patient with novel TK2 mutations. Neuromuscul Disord. 2014;24:713–20.
doi: 10.1016/j.nmd.2014.05.009 pubmed: 24953930
Lin Y, Du J, Wang W, Ren H, Zhao D, Liu F, Lin P, Ji K, Zhao Y, Yan C. Novel biallelic mutations in POLG gene: large deletion and missense variant associated with PEO. Neurol Sci. 2021;42:4271–80.
doi: 10.1007/s10072-021-05380-2 pubmed: 34189666
Rio D, Ares M, Hannon G, Nilsen T. Purification of RNA using TRIzol (TRI reagent). Cold Spring Harb Protoc 2010, 2010:pdb.prot5439.
Qian W, Kumar N, Roginskaya V, Fouquerel E, Opresko P, Shiva S, Watkins S, Kolodieznyi D, Bruchez M, Van Houten B. Chemoptogenetic damage to mitochondria causes rapid telomere dysfunction. Proc Natl Acad Sci U S A. 2019;116:18435–44.
doi: 10.1073/pnas.1910574116 pubmed: 31451640 pmcid: 6744920
Birch-Machin M, Turnbull D. Assaying mitochondrial respiratory complex activity in mitochondria isolated from human cells and tissues. Methods Cell Biol. 2001;65:97–117.
doi: 10.1016/S0091-679X(01)65006-4 pubmed: 11381612
MITOMAP. a human mitochondrial genome database [ http://www.mitomap.org/MITOMAP ]
Wang Y, Xu E, Musich PR, Lin F. Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure. CNS Neurosci Ther. 2019;25:816–24.
doi: 10.1111/cns.13116 pubmed: 30889315 pmcid: 6566063
Soldatov VO, Kubekina MV, Skorkina MY, Belykh AE, Egorova TV, Korokin MV, Pokrovskiy MV, Deykin AV, Angelova PR. Current advances in gene therapy of mitochondrial diseases. J Transl Med. 2022;20:562.
doi: 10.1186/s12967-022-03685-0 pubmed: 36471396 pmcid: 9724384
Suzuki T. The expanding world of tRNA modifications and their disease relevance. Nat Rev Mol Cell Biol. 2021;22:375–92.
doi: 10.1038/s41580-021-00342-0 pubmed: 33658722
Ruiz-Arroyo VM, Raj R, Babu K, Onolbaatar O, Roberts PH, Nam Y. Structures and mechanisms of tRNA methylation by METTL1-WDR4. Nature. 2023;613:383–90.
doi: 10.1038/s41586-022-05565-5 pubmed: 36599982 pmcid: 9930641
Lin S, Liu Q, Lelyveld VS, Choe J, Szostak JW, Gregory RI. Mettl1/Wdr4-Mediated m(7)G tRNA methylome is required for normal mRNA translation and embryonic stem cell Self-Renewal and differentiation. Mol Cell. 2018;71:244–e255245.
doi: 10.1016/j.molcel.2018.06.001 pubmed: 29983320 pmcid: 6086580
Liu L, Wu J, Lu C, Ma Y, Wang J, Xu J, Yang X, Zhang X, Wang H, Xu J, Zhang J. WTAP-mediated m(6)a modification of lncRNA Snhg1 improves myocardial ischemia-reperfusion injury via miR-361-5p/OPA1-dependent mitochondrial fusion. J Transl Med. 2024;22:499.
doi: 10.1186/s12967-024-05330-4 pubmed: 38796415 pmcid: 11128115
Fergus C, Barnes D, Alqasem M, Kelly V. The queuine micronutrient: charting a course from microbe to man. Nutrients. 2015;7:2897–929.
doi: 10.3390/nu7042897 pubmed: 25884661 pmcid: 4425180
Richard P, Kozlowski L, Guillorit H, Garnier P, McKnight NC, Danchin A, Manière X. Queuine, a bacterial-derived hypermodified nucleobase, shows protection in in vitro models of neurodegeneration. PLoS ONE. 2021;16:e0253216.
doi: 10.1371/journal.pone.0253216 pubmed: 34379627 pmcid: 8357117
Ivanov P, Emara MM, Villen J, Gygi SP, Anderson P. Angiogenin-induced tRNA fragments inhibit translation initiation. Mol Cell. 2011;43:613–23.
doi: 10.1016/j.molcel.2011.06.022 pubmed: 21855800 pmcid: 3160621
Ivanov P, O’Day E, Emara MM, Wagner G, Lieberman J, Anderson P. G-quadruplex structures contribute to the neuroprotective effects of angiogenin-induced tRNA fragments. Proc Natl Acad Sci U S A. 2014;111:18201–6.
doi: 10.1073/pnas.1407361111 pubmed: 25404306 pmcid: 4280610
Hung SH, Elliott GI, Ramkumar TR, et al. Structural basis of Qng1-mediated salvage of the micronutrient queuine from queuosine-5’-monophosphate as the biological substrate. Nucleic Acids Res. 2023;51:935–51.
doi: 10.1093/nar/gkac1231 pubmed: 36610787 pmcid: 9881137
Rakovich T, Boland C, Bernstein I, Chikwana VM, Iwata-Reuyl D, Kelly VP. Queuosine deficiency in eukaryotes compromises tyrosine production through increased tetrahydrobiopterin oxidation. J Biol Chem. 2011;286:19354–63.
doi: 10.1074/jbc.M111.219576 pubmed: 21487017 pmcid: 3103313
Hayes P, Fergus C, Ghanim M, Cirzi C, Burtnyak L, McGrenaghan CJ, Tuorto F, Nolan DP, Kelly VP. Queuine Micronutrient Deficiency promotes Warburg metabolism and reversal of the mitochondrial ATP synthase in Hela Cells. Nutrients 2020, 12.
Varghese S, Cotter M, Chevot F, Fergus C, Cunningham C, Mills KH, Connon SJ, Southern JM, Kelly VP. In vivo modification of tRNA with an artificial nucleobase leads to full disease remission in an animal model of multiple sclerosis. Nucleic Acids Res. 2017;45:2029–39.
pubmed: 28204548

Auteurs

Yan Lin (Y)

Department of Neurology, Shandong Key Laboratory of Mitochondrial Medicine and Rare Diseases, Research Institute of Neuromuscular and Neurodegenerative Diseases, Qilu Hospital of Shandong University, No. 107 West Wenhua Road Jinan, Jinan, Shandong, 250012, China.

Jiayin Wang (J)

Department of Neurology, Shandong Key Laboratory of Mitochondrial Medicine and Rare Diseases, Research Institute of Neuromuscular and Neurodegenerative Diseases, Qilu Hospital of Shandong University, No. 107 West Wenhua Road Jinan, Jinan, Shandong, 250012, China.

Xingyu Zhuang (X)

Department of Neurology, Shandong Key Laboratory of Mitochondrial Medicine and Rare Diseases, Research Institute of Neuromuscular and Neurodegenerative Diseases, Qilu Hospital of Shandong University, No. 107 West Wenhua Road Jinan, Jinan, Shandong, 250012, China.

Ying Zhao (Y)

Department of Neurology, Shandong Key Laboratory of Mitochondrial Medicine and Rare Diseases, Research Institute of Neuromuscular and Neurodegenerative Diseases, Qilu Hospital of Shandong University, No. 107 West Wenhua Road Jinan, Jinan, Shandong, 250012, China.

Wei Wang (W)

Department of Neurology, Shandong Key Laboratory of Mitochondrial Medicine and Rare Diseases, Research Institute of Neuromuscular and Neurodegenerative Diseases, Qilu Hospital of Shandong University, No. 107 West Wenhua Road Jinan, Jinan, Shandong, 250012, China.

Dongdong Wang (D)

Department of Neurology, Shandong Key Laboratory of Mitochondrial Medicine and Rare Diseases, Research Institute of Neuromuscular and Neurodegenerative Diseases, Qilu Hospital of Shandong University, No. 107 West Wenhua Road Jinan, Jinan, Shandong, 250012, China.

Yuying Zhao (Y)

Department of Neurology, Shandong Key Laboratory of Mitochondrial Medicine and Rare Diseases, Research Institute of Neuromuscular and Neurodegenerative Diseases, Qilu Hospital of Shandong University, No. 107 West Wenhua Road Jinan, Jinan, Shandong, 250012, China.

Chuanzhu Yan (C)

Department of Neurology, Shandong Key Laboratory of Mitochondrial Medicine and Rare Diseases, Research Institute of Neuromuscular and Neurodegenerative Diseases, Qilu Hospital of Shandong University, No. 107 West Wenhua Road Jinan, Jinan, Shandong, 250012, China. czyan@sdu.edu.cn.
Qingdao Key Laboratory of Mitochondrial Medicine and Rare Disease, Qilu Hospital (Qingdao), Shandong University, Qingdao, Shandong, 266035, China. czyan@sdu.edu.cn.

Kunqian Ji (K)

Department of Neurology, Shandong Key Laboratory of Mitochondrial Medicine and Rare Diseases, Research Institute of Neuromuscular and Neurodegenerative Diseases, Qilu Hospital of Shandong University, No. 107 West Wenhua Road Jinan, Jinan, Shandong, 250012, China. jikunqian@email.sdu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH